These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18821147)

  • 1. CroFab reconstitution in various media: an in vitro solubility study.
    Vohra R; Clark R; Kelner M
    Clin Toxicol (Phila); 2008 Nov; 46(9):808-10. PubMed ID: 18821147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of crotaline F-ab antivenom (CroFab) with automated mixing methods: in vitro observations.
    Vohra R; Kelner M; Clark RF
    Clin Toxicol (Phila); 2009 Jan; 47(1):69-71. PubMed ID: 19153853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
    de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
    J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating a faster method for reconstitution of Crotalidae Polyvalent Immune Fab (ovine).
    Gerring D; King TR; Branton R
    Toxicon; 2013 Jul; 69():42-9. PubMed ID: 23305624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crotalidae polyvalent immune Fab antivenom limits the decrease in perfusion pressure of the anterior leg compartment in a porcine crotaline envenomation model.
    Tanen DA; Danish DC; Clark RF
    Ann Emerg Med; 2003 Mar; 41(3):384-90. PubMed ID: 12605206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
    Cannon R; Ruha AM; Kashani J
    Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model.
    Offerman SR; Barry JD; Richardson WH; Tong T; Tanen D; Bush SP; Clark RF
    Clin Toxicol (Phila); 2009 Jan; 47(1):61-8. PubMed ID: 19153852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical stability of palonosetron HCl in 4 infusion solutions.
    Trissel LA; Xu QA
    Ann Pharmacother; 2004 Oct; 38(10):1608-11. PubMed ID: 15328393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrated simulation and assessment of the impacts of process change in biotherapeutic antibody production.
    Chhatre S; Jones C; Francis R; O'Donovan K; Titchener-Hooker N; Newcombe A; Keshavarz-Moore E
    Biotechnol Prog; 2006; 22(6):1612-20. PubMed ID: 17137309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of Crotalidae Polyvalent Immune Fab in pediatric crotaline envenomations.
    Pizon AF; Riley BD; LoVecchio F; Gill R
    Acad Emerg Med; 2007 Apr; 14(4):373-6. PubMed ID: 17296804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Hextend impair coagulation compared to 6% hetastarch? An ex vivo thromboelastography study.
    Weeks DL; Jahr JS; Lim JC; Butch AW; Driessen B
    Am J Ther; 2008; 15(3):225-30. PubMed ID: 18496260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniotic fluid volume responses to amnio-infusion of amniotic fluid versus lactated Ringer's solution in fetal sheep.
    Brace RA; Cheung CY
    J Soc Gynecol Investig; 2004 Sep; 11(6):363-8. PubMed ID: 15350248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of meropenem in normal saline solution after storage at room temperature.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Crotalidae polyvalent immune Fab reconstitution times.
    Quan AN; Quan D; Curry SC
    Am J Emerg Med; 2010 Jun; 28(5):593-5. PubMed ID: 20579555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility of injectable Valium in intravenous solutions.
    Grower MF; Russell EA; Getter L
    Anesth Prog; 1978; 25(5):158-60. PubMed ID: 292338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin sodium solubility in three intravenous solutions.
    Pfeifle CE; Adler DS; Gannaway WL
    Am J Hosp Pharm; 1981 Mar; 38(3):358-62. PubMed ID: 7223749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and renal clearances of lactated Ringer's solution in pediatric and adult patients just before anesthesia is induced.
    Li Y; Hahn RG; Hu Y; Xiang Y; Zhu S
    Paediatr Anaesth; 2009 Jul; 19(7):682-7. PubMed ID: 19638113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of normal saline vs. lactated ringer's during renal transplantation.
    Khajavi MR; Etezadi F; Moharari RS; Imani F; Meysamie AP; Khashayar P; Najafi A
    Ren Fail; 2008; 30(5):535-9. PubMed ID: 18569935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between drugs and intravenous delivery systems.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1982 Mar; 39(3):460-7. PubMed ID: 7072732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.